share_log

回盛生物(300871.SZ):不向下修正“回盛转债”转股价格

Huisheng Biotech (300871.SZ): Does not revise the “Huisheng Convertible Bonds” stock conversion price downward

Gelonghui Finance ·  Sep 13, 2023 06:46

Gelonghui September 13?300871.SZ announced that as of September 13, 2023, the share price of Wuhan Huisheng Biotechnology Co., Ltd. has been lower than 85% of the conversion price for at least 15 consecutive trading days from August 24, 2023 to September 13, 2023, triggering a downward amendment to the conversion price of "Huisheng convertible bonds".

After being examined and approved by the sixth meeting of the third session of the board of directors of the company, the board of directors of the company decided not to revise the conversion price this time, and within six months from the next trading date (September 14, 2023 to March 13, 2024), if the downward amendment of the conversion price of "Huisheng convertible bonds" is triggered again, no downward amendment plan will be proposed. The next period that triggers the conditions for the amendment of the conversion price will be re-calculated from March 14, 2024, if the downward amendment of the conversion price of "Hui Sheng convertible bonds" is triggered again, at that time, the board of directors of the company will meet again to decide whether to exercise the downward amendment right of the conversion price of "Hui Sheng convertible bonds".

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment